Insider Transactions in Q4 2020 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 21
2020
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
829
-0.35%
|
$4,145
$5.68 P/Share
|
Dec 21
2020
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+0.8%
|
-
|
Dec 21
2020
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
1,728
-2.88%
|
$8,640
$5.68 P/Share
|
Dec 21
2020
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,438
+5.42%
|
-
|
Dec 15
2020
|
Lindsey Rolfe Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,153
-20.01%
|
$70,765
$5.11 P/Share
|
Dec 15
2020
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,241
+19.6%
|
$51,723
$3.28 P/Share
|
Dec 10
2020
|
Gillian C Ivers Read Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
52,447
-18.44%
|
$209,788
$4.81 P/Share
|
Dec 10
2020
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,965
+19.51%
|
$206,895
$3.28 P/Share
|
Dec 03
2020
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
457
-0.66%
|
$1,828
$4.89 P/Share
|
Dec 03
2020
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,031
+1.46%
|
-
|
Dec 03
2020
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
581
-0.13%
|
$2,324
$4.89 P/Share
|
Dec 03
2020
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,312
+0.3%
|
-
|
Dec 03
2020
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
661
-0.62%
|
$2,644
$4.89 P/Share
|
Dec 03
2020
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,312
+1.21%
|
-
|
Dec 03
2020
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
457
-0.74%
|
$1,828
$4.89 P/Share
|
Dec 03
2020
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,031
+1.65%
|
-
|
Dec 03
2020
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
188
-2.64%
|
$752
$4.89 P/Share
|
Dec 03
2020
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
539
+7.03%
|
-
|
Nov 09
2020
|
Brian G Atwood Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,896
+17.39%
|
$20,688
$3.08 P/Share
|
Nov 03
2020
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
2,534
-3.66%
|
$10,136
$4.93 P/Share
|
Nov 03
2020
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,623
+7.5%
|
-
|
Nov 03
2020
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,623
+8.41%
|
-
|
Nov 03
2020
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
1,152
-3.89%
|
$4,608
$4.93 P/Share
|
Nov 03
2020
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
1,689
-0.78%
|
$6,756
$4.93 P/Share
|
Nov 03
2020
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,749
+1.7%
|
-
|
Nov 03
2020
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
1,920
-3.51%
|
$7,680
$4.93 P/Share
|
Nov 03
2020
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,749
+6.41%
|
-
|